HbF Peak Correction in Cation-Exchange Chromatography

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for measuring hemoglobin F (HbF) in blood samples are inaccurate due to the overlap of peaks from hemoglobin A1a, A1b, and modified HbF, which are difficult to separate using cation-exchange chromatography, leading to an inability to accurately determine the total HbF concentration.

Innovation Solution

A method involving the use of correlation equations to correct the HbF peak value by subtracting the composite peak value of HbA1a and HbA1b from the measured HbA1c peak value, and optionally adding an estimated modified HbF peak value, to accurately determine the total HbF concentration.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of manufacture

If cation-exchange liquid chromatography is used to separate hemoglobin types, then the separation process is simple and widely applicable, but the composite peak of HbA1a, HbA1b, and modified HbF cannot be resolved, leading to inaccurate HbF measurement

Engineering Contradiction:
Improvesimplicity of separation methodVSAvoidaccuracy of HbF measurement
Core Design Contradiction:
Ease of manufactureVSMeasurement precision

Solution Approach 1:

The composite peak area is segmented into multiple components: HbA1a peak area, HbA1b peak area, and modified HbF peak area. By establishing correlation equations between these segments and the total composite peak area, the method enables accurate quantification of each component without requiring physical separation, thus resolving the contradiction between method simplicity and measurement accuracy.

Inventive Principle:
Principle #1Segmentation

2Measurement precision

If the resolution between adjacent peaks (HbA1a, HbA1b, HbF) is increased to improve measurement accuracy, then the separation complexity and analysis time increase significantly

Engineering Contradiction:
Improveresolution between peaksVSAvoidanalysis time
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The method performs preliminary establishment of correlation equations between peak areas and hemoglobin concentrations using standard samples with known compositions. These pre-established correlations are then applied to unknown samples, eliminating the need for time-consuming optimization of separation conditions for each sample while maintaining accurate measurement.

Inventive Principle:
Principle #10Preliminary action

3Measurement precision

If the elution conditions are optimized to separate modified HbF from HbA1a and HbA1b, then the measurement accuracy improves, but the device complexity and method complexity increase

Engineering Contradiction:
Improveability to separate modified HbFVSAvoidcomplexity of separation conditions
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The method uses the composite peak area as an intermediary parameter to indirectly determine the concentration of modified HbF. Instead of directly separating and measuring modified HbF (which would require complex conditions), the correlation between the composite peak area and modified HbF concentration is established, allowing accurate measurement through simpler chromatographic conditions.

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables more precise measurement of HbF by correcting for the modified HbF component, thereby improving the accuracy of HbF quantification in blood samples.

Implementation Method 1

a chromatogram obtained by subjecting a blood sample to cation-exchange liquid chromatography

Methodology Applied
Scientific EffectCation-exchange chromatography: Ion Exchange

Data Source

PatentEP4249905B1Method of measuring hemoglobin f
Publication Date: 2025.12.24 ARKRAY INC
  • EP4249905B1 patent drawingFigure 1~3
  • EP4249905B1 patent drawingFigure 4~5
  • EP4249905B1 patent drawingFigure 6~7

AI summary

A first correlation equation is preliminarily determined from a chromatogram obtained by subjecting, to liquid chromatography, a first blood sample group which is known to contain HbA1c, and whose content ratio of HbF in total hemoglobin is known to be less than a predetermined content ratio, the first correlation equation being a correlation equation between an HbA1c peak value and a composite peak value including an HbA1a peak (11) and an HbA1b peak (12). A composite peak value obtained by applying, to the first correlation equation, an HbA1c peak value of a chromatogram obtained by subjecting a measurement target blood sample to liquid chromatography is subtracted from a composite peak value including an HbA1a peak (11) and an HbA1b peak (12) in the blood sample, to calculate a modified HbF peak value. The modified HbF peak value is added to an HbF peak value of the blood sample, to correct the HbF peak value.